| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2005 | CN1646688A Growth regulating proteins |
| 07/27/2005 | CN1646568A Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 07/27/2005 | CN1646556A Blanched polyamine steroid derivatives |
| 07/27/2005 | CN1646555A Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations |
| 07/27/2005 | CN1646539A The synthesis of naturally occuring ecteinascidins and related compounds |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646534A Modified fluorinated nucleoside analogues |
| 07/27/2005 | CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646530A Nitrosated imidazopyridines |
| 07/27/2005 | CN1646528A Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 07/27/2005 | CN1646527A Medicaments containing BETAMIMETICS drugs and a novel anticholinesterase drug |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646525A Process for 5-[[2(R)-[1(R)-[3, 5-bis(trifluoromethyl)phenyl]ethoxy]-3(S)-(4-fluorophenyl)-4-morpholinyl]methyl]-1, 2-dihydro-3H-1, 2, 4-triazol-3-one |
| 07/27/2005 | CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646519A N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
| 07/27/2005 | CN1646515A Medicinal composition for improving angiotension-regulating function of blood vessel endothelium |
| 07/27/2005 | CN1646513A An antimicrobial agent |
| 07/27/2005 | CN1646509A Piperazinyl- or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646507A Aminophenylbenzothiazole compounds |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
| 07/27/2005 | CN1646500A Aryl substituted pyrimidines and the use thereof |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646498A Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646496A Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646492A Chain oligolactic acid thioester |
| 07/27/2005 | CN1646491A Compounds used to prepare camptothecin derivatives |
| 07/27/2005 | CN1646490A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX |
| 07/27/2005 | CN1646485A Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 07/27/2005 | CN1646481A Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646479A Irreversible selective androgen receptor modulators and methods of use thereof |
| 07/27/2005 | CN1646473A Novel curcumin analogues and uses thereof |
| 07/27/2005 | CN1646462A Hyperforin derivatives, the use thereof and formulations containing them |
| 07/27/2005 | CN1646461A Hyperforin halogenated derivatives, the use thereof and formulations containing them |
| 07/27/2005 | CN1646460A 2-(2, 6-dichlorophenyl)-diarylimidazoles |
| 07/27/2005 | CN1646193A Bisphosphonic acid for the treatment and prevention of osteoporosis |
| 07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/27/2005 | CN1646169A Injectable veterinary composition for small animals |
| 07/27/2005 | CN1646168A Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
| 07/27/2005 | CN1646167A Treatment of metabolic syndrome |
| 07/27/2005 | CN1646166A Method and composition for potentiating an opiate analgesic |
| 07/27/2005 | CN1646165A Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/27/2005 | CN1646164A Process for the preparation of a nutrient formulation |
| 07/27/2005 | CN1646163A Administration of agents for the treatment of inflammation |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646156A Strategy for retroviral immunotherapy |
| 07/27/2005 | CN1646155A Cancer therapy |
| 07/27/2005 | CN1646151A Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 07/27/2005 | CN1646150A Novel use of the extract of processed ginseng and saponin isolated therefrom |
| 07/27/2005 | CN1646149A Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family |
| 07/27/2005 | CN1646144A Remedies |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646142A Method of treating arrhythmias comprising administration of an A1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 07/27/2005 | CN1646140A Use of a compound having the ability to release CO in preparation of pharmaceutical compositions for treatment of inflammation |
| 07/27/2005 | CN1646139A Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646137A Method for treating and preventing hyperparathyroidism |
| 07/27/2005 | CN1646136A Pharmaceutical compositions comprising active vitamin D compounds |
| 07/27/2005 | CN1646135A Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 07/27/2005 | CN1646134A Method and composition for treatment of ocular hypertension and glaucoma |
| 07/27/2005 | CN1646133A Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 07/27/2005 | CN1646132A Methods of treating patients suffering from movement disorders |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646130A Treatment of rheumatoid arthritis |
| 07/27/2005 | CN1646129A Dosing regimen for gemcitabine HCV therapy |
| 07/27/2005 | CN1646128A Solid dispersion composition |
| 07/27/2005 | CN1646127A Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias |
| 07/27/2005 | CN1646126A Medicaments containing steroids and a novel anticholinesterase drug |
| 07/27/2005 | CN1646124A Use of materials having zinc ionophoric behavior |
| 07/27/2005 | CN1646123A Therapeutic agent for food competence disorder in stomach |
| 07/27/2005 | CN1646122A A medicament for preventing and/or treating chronic rejection |
| 07/27/2005 | CN1646121A Methods for modulating phototoxicity |
| 07/27/2005 | CN1646120A Antineoplastic combinations |
| 07/27/2005 | CN1646119A Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2005 | CN1646118A Pharmaceutical composition for preventing or treating respiratory disease |
| 07/27/2005 | CN1646117A Low-pressure mercury vapor discharge lamp |
| 07/27/2005 | CN1646115A Treating benign prostate hyperplasia with SARMS |
| 07/27/2005 | CN1646114A Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 07/27/2005 | CN1646113A Cell proliferating agents |
| 07/27/2005 | CN1646112A A herbal molecule as potential anti-leukemic drug |
| 07/27/2005 | CN1646111A Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 07/27/2005 | CN1646110A Tolterodine salts |
| 07/27/2005 | CN1646109A Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 07/27/2005 | CN1646108A Aerosol formulation for inhalation comprising a tiotropium salt |
| 07/27/2005 | CN1646106A Capsule preparation |
| 07/27/2005 | CN1646104A Dry granulated formulations of azithromycin |
| 07/27/2005 | CN1646103A 高药物载荷片剂 High drug load tablets |
| 07/27/2005 | CN1646102A Pharmaceutical preparation containing oxycodone and naloxone |
| 07/27/2005 | CN1646101A Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations |
| 07/27/2005 | CN1646099A Powder formulations suitable for inhalation |